Assessment of the necessity of eye draping for intravitreal injection under the use of the disposable eye speculum

Assessment of the necessity of eye draping for intravitreal injection under the use of the disposable eye speculum - Eye Speculum study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005114

Enrollment

260

Registered

2011-02-28

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exudative age-related macular degeneration

Interventions

Intravitreal injection with draping Intravitreal injection without draping

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subject who has exudative AMD and be scheduled intravitreal injection of Ranibizumab or Pegaptanib for the first time.

Exclusion criteria

Exclusion criteria: 1)Immunocompromised status 2)Difficulty to have intravitreal injection 3)Case who was judged inapropriate for examination object (progressing glaucoma etc.) 4)Atopic dermatitis 5)Hypersensitivity against antiseptic substance 6)Treated with antimicrobial agent not for intravitreal injection two weeks before the first injection.

Design outcomes

Primary

Measure	Time frame
comparison of bacterial isolation rate between the groups with- and without-draping	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026